reports
- Alan Vandenberghe
- Bart Cuypers
- Guy Sips
- Jason Kalamboussis
- Joachim Vansanten
- Lenny Van Steenhuyse
- Michiel Declercq
- Ruben Devos
- Thomas Couvreur
- Wido Jongman
- Wim Hoste
THEMATIC NOTE : BIG THINGS COME IN SMALL PACKAGES
Small-cap stocks can be smart long-term holdings, but knowing the best time to buy small-caps may even boost long-term returns. There are some smart ways for active investors to potentially enhance long-term performance by playing around with their exposure to small-cap stocks. We prove that it can be useful to choose an appropriate allocation of small-cap stock and stick to the allocation for the longer term. It can be appropriate to rebalance your portfolio, such as once per quarter or once pe...
IMMO COMPAGNIE IMMOBILIERE DE BELGIQUE SA
SIP SIPEF GROUP
RES RESILUX N.V.
QFG QUEST FOR GROWTH
ONCOB MDXHEALTH S.A.
QRF QRF COMM
CPINV CARE PROPERTY INVEST SA
ONTEX ONTEX GROUP N.V.
MITRA N.V. MITHRA PHARMACEUTICALS S.A.
BCART BIOCARTIS GROUP NV
IVA INVENTIVA SA
OBEL ORANGE BELGIUM SA
SEQUA SEQUANA MEDICAL
HYL HYLORIS PHARMACEUTICALS
- Alan Vandenberghe
- Bart Cuypers
- Jason Kalamboussis
- Lenny Van Steenhuyse
- Michiel Declercq
- Ruben Devos
- Sandra Cauwenberghs
- Thomas Couvreur
- Wim Hoste
MORNING NOTE : BCART BB, COLR BB, ECONB BB, GIMB BB, HYL BB, INGA NA,...
Biocartis : Joining a powerhouse COVID-19 consortium Colruyt : Guiding for flat underlying profit growth Econocom : Interim dividend proposal of €0.12 Gimv : Invests in medical diagnostics company Biolam Hyloris : Dr Aichhorn as COO ING : Call with New CEO: focus on Costs, “clamp down” Kiadis : Feedback 1H20 call / Debt restructuring w Kreos Proximus : BIPT says commercial FttH wholesale rates are fair SBM Offshore : Prosperity is coming Various : Dynamic Top Pick List update – In: Telenet
- Jason Kalamboussis
- Michiel Declercq
- Sandra Cauwenberghs
- Wim Hoste
- Jason Kalamboussis
- Joachim Vansanten
- Lenny Van Steenhuyse
- Sandra Cauwenberghs
- Wido Jongman
- Wim Hoste
MORNING NOTE : AGS BB, CYAD BB, CRBN NA, DECB BB, FAGR BB, GLPG NA, HY...
Please find today's news on the following companies : Ageas : 2Q reinforces our positive view, upgrading to BUY Celyad : 1H20 - update on covid impact and cash at € 27m Corbion : Better than expected 2Q, FY margin guidance upped Deceuninck : Preview 1H: revenue -11% and adj EBITDA -18% Fagron : Resilient, defensive, growing: a valuable combo Galapagos : 1H20 results: Filgotinib phase III trials resumed Hyloris : Creating value through complex drug reformulation MDxHealth : Hickup in SelectMDx...
- Lenny Van Steenhuyse
- Sandra Cauwenberghs
HYLORIS - Initiation 07.08.20 - Creating value through complex drug re...
Today we initiate coverage on Hyloris Pharmaceuticals, an early-stage innovative specialty branded pharma company focused on adding value through the reformulation of well-known pharmaceutical drugs. As such it fills a gap in the healthcare system that has been left unaddressed by large pharma companies. Target price of € 11.5/share and Buy rating
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.